BMS is in close contact with Healthcare Liability reinsurance underwriters to best understand what impact COVID-19 will have on their portfolios and appetite for risk going forward. Similar to our findings across the industry, BMS has found our
reinsurance partners efficiently working remotely, responding timely, and receptive to hearing our clients’ messages. Our findings encompass views from 50% of the MPL reinsurance marketplace, measured by healthcare written premium.